Navigation Links
pH 200 series, F 250 Handheld, pH/Temp/mV Meter

ProductspH 200 series, F 250 Handheld, pH/Temp/mV Meter
Company Beckman Coulter, Inc.
Item pH 200 series, F 250 Handheld, pH/Temp/mV Meter
Features Inquire
Description The F 250 is a portable system for routine pH, mV (ORP), relative mV and temperature measurements. Temperature compensated pH results can be obtained when used with a temperature probe (ATC) or a 3-in-1 electrode. • Fast and easy one-, two- and three-point calibration with Auto-Find automatic buffer recognition for five buffers (pH 1.68, 4.00, 7.00, 10.01 and 12.45) and Auto-Read for locking onto stable readings. Standard buffers can be substituted with alternate buffers (pH 6.86, 7.41, 9.18 and 11.88) while maintaining automatic buffer recognition and temperature stabilization • Continuous display of calibration buffers. The temperature can be displayed in either °C or °F. • The LCD displays results, temperature, status messages and icons. A tactile keyboard makes it easy and convenient to operate the system. The meter can be operated either on battery or with an optional AC adapter. When operating on battery, the automatic power shut-off becomes active.
Info Beckman Coulter, Inc.
Customer Service: (800) 742-2345
Web site: http://www.beckmancoulter.com

Related medicine products :

1. pH 200 series, F 295 Handheld, Water-Proof pH/Temp/mV/ISE Meter
2. pH 200 series, F 265 Handheld, Water-Proof pH/Temp/mV Meter With Electrode
3. pH 200 series, F 255 Handheld, Water-Proof pH/Temp/mV Meter
4. pH 200 series, F 260 Handheld, pH/Temp/mV Meter
5. pH 200 series, F 265 Handheld, Water-Proof pH/Temp/mV Meter
6. pH 200 series, F 240 Handheld, pH/Temp Meter
7. 1-Meter Roll-Up Tangent Screen
8. HemoSite Meter
9. Retinal Acuity Meter, RAM®
10. Retinal Acuity Meter, RAM
11. HemoSite® Meter
For the quantitative determination of Magnesium in serum. Linearity: 4.0 mEq/L. Working Reagent prepared by simple 1:10 dilution.
For the quantitative determination of total glucose in serum.
Glucose reagent is used for the quantitative determination of glucose in human serum.
Intended for the quantitative determination of glucose in biological fluids. Reaction: endpoint. Wavelength: 340 nm. Linearity: 800 mg/dL (44.4 mmol/L). Single vial, dry powder reagent.
Medicine Products:
(Date:11/21/2008)...-USNewswire/ -- The Generic,Pharmaceutical Associ...y from,GPhA President and CEO Kathleen Jaeger reg...ble on "Emerging Health Care Competition and Consu...is conducting this roundtable demonstrates the,gr... access to safe and,affordable biogenerics sooner...
(Date:11/21/2008)...ve against Lennox-Gastaut syndrome , , F...ed Banzel (rufinamide) has been approved as a supp...called Lennox-Gastaut syndrome, the U.S. Food and ...roval was based on results of a four-month clinica...red to patients who took a placebo, those who took...
(Date:11/21/2008)...wire/ -- The University of Texas M. D. Anderson ...ive effort to eradicate breast cancer in Panama th...and Research of the Americas today at an event wit... and Vivian Fernandez de Torrijos, the First Lady ...e initiative are the U.S. Department of State and ...
(Date:11/21/2008)...-- NursingCenter.com, the premier site,for online...ntent, has been,updated to improve the interactiv...wered by Lippincott Williams & Wilkins (LWW), ...ewed continuing education activities and free,acc...ursing journals.,Lippincott Williams & Wilkin...
Breaking Medicine News(10 mins):Health News:GPhA Statement on FTC Roundtable on Biogenerics 2Health News:FDA Approves New Drug for Severe Epilepsy 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3Health News:NursingCenter.com Launches New Features to Improve User Experience 2Health News:NursingCenter.com Launches New Features to Improve User Experience 3
...fat the miss, is Texas A&M University. The univers... line-Whole Harvest Culinary Oils. This change is ...odd eateries on campus. Students eat at campus fa...le dining halls, restaurants and food court specia...
...eadaches, but patients should be warned of the ris...scrasias"), concluded a Cochrane Review team. Furt... conclusion involved intravenous infusions of the ...to deliver. Dipyrone is a non-opioid painkiller t...
... aneurysms can sharply reduce the likelihood of dy...d older, according to a new review of recent studi... in half for men ages 65 to 79 but did not reduce ...r, men who received screening were also twice as l...
...r continues unabated. One more firm has said it is... that animals fed the brands had vomited and also ...ood manufacturer has recalled its products on rece...experiencing kidney problems, the Food and Drug Ad...
Other Medicine News:Health News:Screening for Abdominal Aortic Aneurysms Saves Men's Lives 2Health News:Two More Pet Food Products Recalled in US 2Health News:Two More Pet Food Products Recalled in US 3
(Date:11/18/2008)...RNewswire-USNewswire/ -- Forty-two leading U. S. s...ational forum to consider cutting-edge innovations...nal economy from outbreaks of dangerous zoonotic d... Among those innovations: , , , , ...ble that detects highly contagious and dangerous z...
(Date:11/13/2008)...3 Hologic, Inc.,(Nasdaq:...pplier of premium,diagnostics, medical imaging sys...e healthcare needs of women, today announced the r...cal trial. The Cervista HPV high-risk,test is curr...xpected to be,launched in the European Union (EU) ...
(Date:11/12/2008)...ewswire-USNewswire/ -- A new study being,published... answer the,question, what causes Parkinson,s dise...edical research into,Parkinson,s disease is what c...he first place. Answering this question has been e...dentical types of brain cells that produce,dopamin...
(Date:11/12/2008)...0128 Provides Reversible, High-level Platelet ... -, NEW ORLEANS and SOUTH SAN FRANCISCO, Calif., ... biopharmaceutical company developing innovative,d...scular and inflammatory,diseases, and cancer, toda...060128, the Company,s novel anti-platelet drug tha...
Breaking Medicine Technology:42 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 3Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 4A Window Into Parkinson's Disease 2Portola Announces Data Showing Its Anti-Platelet Drug Inhibits Platelets in Clopidogrel (Plavix(R)) Non-Responders 2Portola Announces Data Showing Its Anti-Platelet Drug Inhibits Platelets in Clopidogrel (Plavix(R)) Non-Responders 3Health and Business Groups Launch Ad Campaign About Need for Comprehensive Smoke Free Law in Pennsylvania 992 1Health and Business Groups Launch Ad Campaign About Need for Comprehensive Smoke Free Law in Pennsylvania 992 2Health and Business Groups Launch Ad Campaign About Need for Comprehensive Smoke Free Law in Pennsylvania 992 3Slowed Brain Activity in Frequent Mobile Phone Users 989 1Slowed Brain Activity in Frequent Mobile Phone Users 989 2LOreal Paris Celebrates Ten Years of Hope and Healing 986 1LOreal Paris Celebrates Ten Years of Hope and Healing 986 2LOreal Paris Celebrates Ten Years of Hope and Healing 986 3LOreal Paris Celebrates Ten Years of Hope and Healing 986 4LOreal Paris Celebrates Ten Years of Hope and Healing 986 5The Pittsburgh Life Sciences Greenhouse Adds to Its Investment Portfolio 501 1The Pittsburgh Life Sciences Greenhouse Adds to Its Investment Portfolio 501 2The Pittsburgh Life Sciences Greenhouse Adds to Its Investment Portfolio 501 3The Pittsburgh Life Sciences Greenhouse Adds to Its Investment Portfolio 501 4
... 25, 2007 - ARIAD,Pharmaceuticals, Inc. (NASDAQ: A...rom leading cancer centers will present Phase 2 an...any,s novel mTOR,inhibitor, AP23573, at the annual...ogy (ASCO) in Chicago, Illinois, on Sunday, June,3...single-agent,AP23573 in patients with soft-tissue ...
...wswire-FirstCall/ -- Iomai,Corporation today annou...1 trial of its patch-based needle-free influenza v...nce call and live,webcast will be held at 8:30 a.m...Conference Call Details , To access the live confe...rn Time via phone, please dial 888-396-2356 from t...
Other Medicine Technology:Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 2Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 3Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 4Iomai to Announce Results From Phase 1 Influenza Trial and Host,Webcast Tomorrow 2